AU7177494A - Pore-forming and superantigen encoding toxin cassettes for gene therapy - Google Patents

Pore-forming and superantigen encoding toxin cassettes for gene therapy

Info

Publication number
AU7177494A
AU7177494A AU71774/94A AU7177494A AU7177494A AU 7177494 A AU7177494 A AU 7177494A AU 71774/94 A AU71774/94 A AU 71774/94A AU 7177494 A AU7177494 A AU 7177494A AU 7177494 A AU7177494 A AU 7177494A
Authority
AU
Australia
Prior art keywords
cassettes
pore
forming
gene therapy
encoding toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71774/94A
Inventor
Jean-Numa Lapeyre
Frank C Marini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of AU7177494A publication Critical patent/AU7177494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU71774/94A 1993-06-25 1994-06-22 Pore-forming and superantigen encoding toxin cassettes for gene therapy Abandoned AU7177494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8394193A 1993-06-25 1993-06-25
US083941 1993-06-25
PCT/US1994/007091 WO1995000178A1 (en) 1993-06-25 1994-06-22 Pore-forming and superantigen encoding toxin cassettes for gene therapy

Publications (1)

Publication Number Publication Date
AU7177494A true AU7177494A (en) 1995-01-17

Family

ID=22181644

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71774/94A Abandoned AU7177494A (en) 1993-06-25 1994-06-22 Pore-forming and superantigen encoding toxin cassettes for gene therapy

Country Status (2)

Country Link
AU (1) AU7177494A (en)
WO (1) WO1995000178A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2042093C (en) * 1990-05-09 2002-12-24 Gyula Hadlaczky Cell line carrying an excess of mammalian centromeres
EP0817858B1 (en) 1995-03-09 2003-04-23 Austrian Nordic Biotherapeutics AG Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
US5935568A (en) * 1995-05-18 1999-08-10 National Jewish Medical & Research Center Gene therapy for effector cell regulation
US5705151A (en) * 1995-05-18 1998-01-06 National Jewish Center For Immunology & Respiratory Medicine Gene therapy for T cell regulation
US6077697A (en) * 1996-04-10 2000-06-20 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6025155A (en) * 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
DE69738640T2 (en) 1996-08-15 2009-07-16 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services SPATIAL AND TEMPORARY CONTROL OF GENE EXPRESSION BY MEANS OF A HEAT SHOCK PROMOTER IN COMBINATION WITH LOCAL HEAT
JP3645399B2 (en) * 1997-06-09 2005-05-11 住友金属工業株式会社 Endovascular stent
US7795020B2 (en) 1998-01-14 2010-09-14 Morphogenesis, Inc. Tumor cell vaccines
US7348015B2 (en) 1998-01-14 2008-03-25 Morphogenesis, Inc. Antigen modified cancer cell vaccines for cancer therapy
WO1999036433A2 (en) 1998-01-14 1999-07-22 Morphogenesis, Inc. Materials and methods for treating oncological disease
US6900049B2 (en) * 1998-09-10 2005-05-31 Cell Genesys, Inc. Adenovirus vectors containing cell status-specific response elements and methods of use thereof
CA2349506C (en) 2001-06-14 2009-12-08 Duke University A method for selective expression of therapeutic genes by hyperthermia

Also Published As

Publication number Publication date
WO1995000178A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
AU7637694A (en) Controlled multi-pharmaceutical inhaler
AU699706C (en) Improved vectors for gene therapy
AU1825197A (en) Parallel reaction cassette and associated devices
GB9323453D0 (en) Security system for portable hard disk drive
SG43123A1 (en) Linear amplifier control
AU2447692A (en) Fibrinolysis and fibrinogenolysis treatment with plasmin
AU5098393A (en) Recombinant toxin with increased half-life
AU1400195A (en) Obturator and tracheostomy tube containing the obturator
AU2240197A (en) Use of toxin peptides and/or affinity handles for delivery compounds into cells
AU7177494A (en) Pore-forming and superantigen encoding toxin cassettes for gene therapy
AU3502397A (en) Acyltransferase and gene encoding acyltransferase
AU2575395A (en) Gene coding for glycosyltransferase and use thereof
EP0739983A3 (en) Gene encoding lacto-n-biosidase
AU6676594A (en) Magnetic building block playing system
AU2365188A (en) Anti-coleopteran toxin and gene
AU6528494A (en) Nitric oxide combination therapy
AU5455094A (en) Blast media containing mgo
EP0632440A3 (en) Magnetic recording-reproduction apparatus.
AU670864B2 (en) Magnetic therapeutic apparatus
AU5265093A (en) Magnetic disk apparatus
GB9410899D0 (en) System for handling cured form media and cassette therefor
AU1393197A (en) Data encoding and decoding systems
AU2565797A (en) Oxygen inhaler
AU1047495A (en) Plasmin-independent fibrinolysis
EP0623917A3 (en) Magnetic tape apparatus.